Clinical trial Recruiting at 1 site Observational Ages 18 to 75

Ultrasound of abdominal breathing muscles in Parkinson's disease

Official title: The Ultrasonographic Evaluation of Abdominal Accessory Respiratory Muscle Thickness in Patients With Parkinson's Disease: Correlation With Disease Severity and Expiratory Respiratory Muscle Strength

Run by Istanbul Physical Medicine Rehabilitation Training and Research Hospital · NCT07308795 · Data updated 2026-11-12

We will use ultrasound to measure abdominal breathing muscles to see if their thickness relates to disease severity and breathing strength in adults with Parkinson's disease.

More Parkinson Disease (PD) trials

Quick facts

Study typeObservational
Ages18 Years to 75 Years
SexAll
Enrollment36 (estimated)
SponsorIstanbul Physical Medicine Rehabilitation Training and Research Hospital
Government
Locations1 site (Istanbul, BAHÇELİEVLER)
StatusRecruiting
StartedDecember 29, 2025
Main results expectedFebruary 28, 2026
Study endsApril 20, 2026
Registry record updatedJanuary 2, 2026
Trial IDNCT07308795 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with a clinical diagnosis of Parkinson's disease at Hoehn and Yahr stages 1–3 who can follow commands (MMSE >23), have BMI <30, are non-smokers, and can attend the Istanbul study site.

Probably not a fit

People with advanced Parkinson's beyond stage 3, significant cognitive impairment, active chest disease, ongoing smoking, unstable vital signs, or Parkinson-plus syndromes would likely be excluded and may not benefit from these specific findings.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational, cross-sectional study enrolling adults with Parkinson's disease at Hoehn and Yahr stages 1–3. Investigators will use ultrasonography to measure thickness of rectus abdominis, transversus abdominis, and oblique muscles and will record maximal inspiratory and expiratory pressures (MIP and MEP). Disease severity will be captured with standardized clinical scales and cognitive screening will ensure participants can follow instructions. The study will compare muscle thickness with expiratory strength and clinical severity to identify patterns that could inform respiratory rehabilitation.

Why it matters

Potential benefit: If a clear relationship is found, ultrasound measures could help identify respiratory muscle weakness earlier and guide targeted breathing rehabilitation for people with Parkinson's.

How similar studies have gone: Prior studies have documented respiratory muscle weakness in Parkinson's and ultrasonography has been used to measure abdominal muscles in other populations, but correlating abdominal muscle thickness specifically with Parkinson's disease severity is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age \> 18 years
* Parkinson's disease diagnosis with Modified Hoehn and Yahr stages 1-2-3
* Mini-Mental State Examination (MMSE) score \> 23
* Body Mass Index (BMI) \< 30

Exclusion Criteria:

* Active smokers
* Individuals with a diagnosis of active chest disease
* Those with hemodynamic instability
* Individuals with unstable vital signs
* Parkinson's patients who cannot be controlled with medical treatment
* Parkinson Plus syndromes

Where it's running

  • İstanbul Fizik Tedavi Ve Rehabilitasyon Eğitim Ve Araştirma Hastanesi
    Istanbul, Bahçeli̇evler, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.